Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] (2013)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; SIMOES, BELINDA PINTO - FMRP ; SOUZA, ANA MARIA DE - FCFRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.3109/10428194.2013.767453
- Subjects: EXPRESSÃO GÊNICA; APOPTOSE; RNA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Leukemia and Lymphoma
- ISSN: 1042-8194
- Volume/Número/Paginação/Ano: v. 54, n. 9, p. 2047-2051, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NUNES, Natália S et al. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3109/10428194.2013.767453. Acesso em: 05 maio 2024. , 2013 -
APA
Nunes, N. S., Tognon, R., Moura, L. G., Kashima, S., Covas, D. T., Santana, M., et al. (2013). Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3109/10428194.2013.767453 -
NLM
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 maio 05 ] Available from: https://doi.org/10.3109/10428194.2013.767453 -
Vancouver
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 maio 05 ] Available from: https://doi.org/10.3109/10428194.2013.767453 - Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy
- Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia
- Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell
- ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance
- The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms
Informações sobre o DOI: 10.3109/10428194.2013.767453 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
